The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Incidence of colorectal cancer among young adults in the state of Colorado.
 
Christopher Hanyoung Lieu
Consulting or Advisory Role - Merrimack
 
David Sheneman
No Relationships to Disclose
 
Jack L Finch
No Relationships to Disclose
 
Sarah Lindsey Davis
No Relationships to Disclose
 
Stephen Leong
Stock and Other Ownership Interests - Amarin Corporation; Antares Pharmaceuticals; ARIAD; Spectrum Pharmaceuticals
Consulting or Advisory Role - Ipsen; New B Innovation
Research Funding - Pfizer
Travel, Accommodations, Expenses - Pfizer
 
Colin D. Weekes
Honoraria - Celgene; Merrimack
Consulting or Advisory Role - Celgene; Merrimack
Research Funding - Millennium
Other Relationship - Celgene; Genentech/Roche
 
William T. Purcell
No Relationships to Disclose
 
Karyn A. Goodman
Consulting or Advisory Role - Pfizer
 
Wells A. Messersmith
Consulting or Advisory Role - Immunomedics; OncoMed
Research Funding - GlaxoSmithKline; Immunomedics; Millennium; OncoMed; Pfizer; Roche/Genentech
 
S. Gail Eckhardt
Stock and Other Ownership Interests - Entremed
Honoraria - Boehringer Ingelheim; Janssen Oncology; Kyowa Hakko Kirin; Lilly/ImClone
Consulting or Advisory Role - CASI Pharmaceuticals; OnKure; Pfizer; Sanofi; Suvica; Taiho Pharmaceutical
Research Funding - AstraZeneca (Inst); cleave biosciences (Inst); Genentech (Inst); OncoMed (Inst); Rexahn Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Genentech; Kyowa Hakko Kirin; Lilly/ImClone; Sanofi